A study of the prevalence of significant increases in serum creatinine following angiotension-converting enzyme inhibitor administration.
about
Safety and tolerability of azilsartan medoxomil in subjects with essential hypertension: a one-year, phase 3, open-label study.Safety, tolerability, and efficacy of azilsartan medoxomil with or without chlorthalidone during and after 8 months of treatment for hypertensionReview: use of electronic medical records for health outcomes research: a literature review.Monitoring and managing urinary albumin excretion: practical advice for primary care clinicians.Identification and management of albuminuria in the primary care setting.The ZDSD rat: a novel model of diabetic nephropathy.Comparison of long-term safety of fixed-dose combinations azilsartan medoxomil/chlorthalidone vs olmesartan medoxomil/hydrochlorothiazide.
P2860
Q36762587-C3D59079-46AB-42B0-A099-C1007B00DD12Q37257463-B599229C-A52A-4BDF-A9A6-66C0E193EA30Q37412856-41D99564-B8AE-4B0D-8142-647A79B1433BQ37566053-82A6695D-8DF2-4446-B15A-685CCCFDA583Q37886063-1E9306D4-DDF8-45C2-98E1-BF77E8707273Q41965910-AD60007F-43F6-4FE0-9762-FFF7D7972EE7Q46669579-AFBD05AD-2F12-4918-A80A-DD8481953BF4
P2860
A study of the prevalence of significant increases in serum creatinine following angiotension-converting enzyme inhibitor administration.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
A study of the prevalence of s ...... zyme inhibitor administration.
@ast
A study of the prevalence of s ...... zyme inhibitor administration.
@en
type
label
A study of the prevalence of s ...... zyme inhibitor administration.
@ast
A study of the prevalence of s ...... zyme inhibitor administration.
@en
prefLabel
A study of the prevalence of s ...... zyme inhibitor administration.
@ast
A study of the prevalence of s ...... zyme inhibitor administration.
@en
P2093
P2860
P356
P1476
A study of the prevalence of s ...... zyme inhibitor administration.
@en
P2093
Jaderholm PL
P2860
P2888
P304
P356
10.1038/SJ.JHH.1001832
P577
2005-05-01T00:00:00Z